Jun-Yi Wu

11PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 23, 2026
Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple Therapy.

|Jun 18, 2025
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.

Shao-Ming Wei, Zhen-Xin Zeng, Rong-Jian Pan

|Apr 21, 2025
Combination Therapy of Transarterial Chemoembolization, Lenvatinib, and PD-1 Inhibitors Achieves Significant Tumor Response in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Report.

Yangkai Fu, Junyi Wu, Jiayi Wu

|Dec 02, 2024
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study.

De-Yi Liu, Yi-Nan Li, Jia-Yi Wu

|Sep 30, 2024
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.

Zhong-Tai Lin, Shao-Ming Wei, Jun-Yi Wu

|Dec 11, 2023
Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?

Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu

Pageof 2

Frequent Collaborators

4 joint publications

Zhen-Xin Zeng

3 joint publications

Meng-Chao Luo

3 joint publications

Yang-Kai Fu

3 joint publications

Jian-Yin Zhou